Navigation Links
Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
Date:12/4/2007

Two International Phase 3 Trials Evaluated Infrequent Dosing of Ustekinumab

in Nearly 2,000 Patients

HORSHAM, Pa. and BEERSE, Belgium, Dec. 4 /PRNewswire/ -- Centocor, Inc. and Janssen-Cilag International NV announced today that regulatory applications have been submitted requesting the approval of ustekinumab (CNTO 1275) in the United States and Europe for the treatment of adult patients with chronic moderate to severe plaque psoriasis. Centocor has submitted a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) and Janssen-Cilag International NV has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA). Ustekinumab is a new, human monoclonal antibody with a novel mechanism of action that targets the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23), naturally occurring proteins that are important in regulating immune responses and that are thought to be associated with some immune-mediated inflammatory disorders, including psoriasis.

It is estimated that 125 million people worldwide have psoriasis, including two percent of both the U.S. and European populations, or some 7.5 million Americans and 10 million Europeans. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe.(1)

The submissions are based on a comprehensive development program including data from two large Phase 3 multicenter, randomized, double-blind, placebo- controlled trials involving nearly 2,000 patients that evaluated the safety and efficacy of ustekinumab in the treatment of moderate to severe plaque-type psoriasis. The primary endpoint of each pivotal study was the proportion of patients who achieved at least a 75 percent reduction in psoriasis as measured by the Psoriasis Area and Severity Index (PASI 75).

"We are very encouraged by the promising results that we have seen through the ustekinumab clinical developmen
'/>"/>

SOURCE Centocor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
2. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
3. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
4. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
5. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
6. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
7. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... /PRNewswire-iReach/ -- The escalation of new biological drugs, ... emphasis on alternate delivery technologies. Alternate delivery technologies ... factors are converging to create both risk ... device partners . These include new classes of ... toward self-administration for chronic diseases, shifting patient demographics ...
(Date:5/17/2013)... SEATTLE , May 17, 2013  Atossa Genetics, Inc. ... today that Kyle Guse , Chief Financial ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013, in ... Hyatt Hotel. The Company,s presentation is scheduled ... via a live webcast. To access the webcast, go to ...
(Date:5/16/2013)... SINGAPORE and ZURICH , May ... Agency for Science, Technology and Research (A*STAR) and ... the first healthy volunteer has been dosed in a Phase ... on Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In ... of this novel vaccine candidate and its potential to protect ...
Breaking Medicine Technology:Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... 11, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... announced 1-for-20 reverse split of its common stock will ... March 14, 2011. Nephros common stock will be quoted ...
... March 11, 2011 Ferring Pharmaceuticals Inc. congratulates ... receive the inaugural Woman of the Year award ... part of the Foundation,s arthritis awareness initiative, Women ... her formidable personal and professional accomplishments despite being ...
Cached Medicine Technology:Nephros Announces Completion of Reverse Stock Split 2Nephros Announces Completion of Reverse Stock Split 3Nephros Announces Completion of Reverse Stock Split 4Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named 'Woman of the Year' by Arthritis Foundation 2Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named 'Woman of the Year' by Arthritis Foundation 3
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... they have filed a diving accident lawsuit on ... of a tragic dive into shallow water. The diving accident ... State New York, Suffolk County, alleges the Defendant held the ... warnings or signs against diving in the area. (Case No. ...
(Date:5/19/2013)... CO (PRWEB) May 19, 2013 Daily Gossip ... guide 17 Cheat Foods That Burn Fat to ... its readers. , The review is a ... followed by the writer's recommendation. , The two nutritionists have ... that is responsible for the caloric intake and expenditure of ...
(Date:5/19/2013)... May 19 (HealthDay News) -- Although spring arrived late ... summer allergy season will still be strong, according to ... Birmingham. Dr. Richard Waguespack, clinical professor in the ... results in a robust summer allergy season. However, some ... sneezing, wheezing and coughing, he added. "Tree pollen ...
(Date:5/19/2013)... Healthcare leaders will gather at the ... Walt Disney World Swan and Dolphin in Orlando, Fla., ... care delivery and healthcare reform and implementation. , “Reform ... markets, with consolidation, efficiency and reduced payments ... Ebert, Amerinet president and CEO. “There is a real ...
(Date:5/19/2013)... 2013 Actos lawsuit claims ... underway in U.S. District Court, Western District of Louisiana. ... 3rd, the Court has modified the litigation’s Bellwether Nomination ... rather than four. The next Status Conference in the ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
Breaking Medicine News(10 mins):Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 2Health News:Alonso Krangle Files Diving Accident Lawsuit on Behalf of Suffolk County Man Rendered Quadraplegic in Tragic Diving Accident at Long Island Beach 3Health News:The "17 Cheat Foods That Burn Fat" Review and Diet Plan Secrets Revealed by Daily Gossip 2Health News:Managing Seasonal Allergies 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3
... Nutrition research is pointing to ways that nutrients or ... (TBI), raising the possibility that the U.S. Department of ... help personnel who receive a TBI. Nutrition ... Outcomes in Military Personnel, a new report from the ...
... to sleep on his bunk bed one night and never woke ... with his neck caught between the vertical post of his side ... to have strangled in the space between a bunk bed ladder ... Consumer Product Safety Commission (CPSC). In the Forensic Ergonomics Special Issue ...
... School of Medicine and Kent State University shows that ... harder for the cardiovascular system to simultaneously juggle the ... For decades, medical researchers have sought to understand how ... Some individuals, described as "salt sensitive," experience an increase ...
... lack of sleep and strange surroundings can make any ... seniors, hospitalizations actually may cause temporary memory loss and ... Northwestern Medicine study. The seniors go back ... study found. But immediately following a hospitalization is a ...
... News) -- Parents who say "um" and "uh" when speaking ... helping the children learn language more efficiently, according to researchers. ... found that older children paid more attention to an image ... stumbled and said, "Look at the, uh..." When a ...
... polluted air appears to activate a protein that triggers ... that lead to widespread inflammation, according to new research ... gap in researchers, understanding of how prolonged exposure to ... other diseases. The research group, led by Ohio ...
Cached Medicine News:Health News:Human Factors/Ergonomics research leads to improved bunk bed safety standards 2Health News:New study identifies possible cause of salt-induced hypertension 2Health News:New study identifies possible cause of salt-induced hypertension 3Health News:Temporary memory loss strikes hospitalized seniors 2Health News:Polluted air leads to disease by promoting widespread inflammation 2Health News:Polluted air leads to disease by promoting widespread inflammation 3Health News:Polluted air leads to disease by promoting widespread inflammation 4Health News:Polluted air leads to disease by promoting widespread inflammation 5
... Image Processing Video Camera is our new ... ACMI Image Processing (IP) technology, the IP ... detail. Exciting new features, enhanced image quality, ... an exceptional value. All IP 4.2 cameras ...
... Xenon, Metal Halide and Halogen illumination systems ... design. In addition, Olympus provides the highest ... in conjunction with a lightweight, durable design., ... system, but compatible with all surgical endoscopic ...
... VIBROLITH is an intracorporeal electrokinetic lithotripter ... stones. VIBROLITH guarantees satisfaction in application ... bladder, gall bladder and salivary gland ... in percutaneous applications. Kinetic energy transmitted ...
... Medical Solutions is a comprehensive modular solution ... Urodiagnostics, endourology, lithotripsy, prostate diagnostics and therapy, ... of a urologists responsibilities on a given ... supports the various diagnostic or therapeutic applications, ...
Medicine Products: